The mechanism of oxymatrine on atopic dermatitis in mice based on SOCS1/JAK-STAT3 pathway
- PMID: 36703757
- PMCID: PMC9872557
- DOI: 10.3389/fphar.2022.1091090
The mechanism of oxymatrine on atopic dermatitis in mice based on SOCS1/JAK-STAT3 pathway
Abstract
Based on the suppressor of cytokine signaling 1 (SOCS1)/Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathway, the mechanism of oxymatrine in the treatment of atopic dermatitis (AD) was preliminarily explored in this study. C57BL/6 mice were induced to establish AD model by smearing carbotriol (MC903) on their back. The AD mice were randomly divided into model group, oxymatrine groups with three dosages (25, 50 and 100 mg/kg), (n = 10). Oxymatrine groups were intragastric administered once daily for 14 days. The same volume of saline was given in the normal control group and model group once daily for 14 days. Subsequently, HE staining was used to observe the pathological changes of skin tissue, ELISA was used to detect the levels of serum inflammatory factors including interleukin-4, 6 and 17 (IL-4, IL-6, and IL-17), tumor necrosis factor-α (TNF-α) and immunoglobulin E (IgE). Immunohistochemistry was used to detect the expression of suppressor of cytokine signaling 1 and CD3 in skin tissue, and Western blotting was used to detect the proteins in suppressor of cytokine signaling 1/JAK-STAT3 pathway. Compared with the normal control group, the pathological damage of mice in the model group, such as skin hyperplasia, edema, congestion and inflammatory infiltration, aggravated increased significantly. And the expression of serum inflammatory factors, CD3 positive expression and JAK-STAT3 pathway protein in the model group were increased (p < .05), and the expression of suppressor of cytokine signaling 1 protein (p < .05) was decreased. Compared with the model group, the above pathological damage of the mice was reduced, and the serum inflammatory factors, JAK-STAT3 pathway protein, and CD3 positive expression were decreased as a dose-dependant manner (p < .05), and the expression of suppressor of cytokine signaling 1 protein was increased as a dose-dependent manner (p < .05). Oxymatrine can improve the skin inflammation symptoms of AD mice by up regulating the expression of suppressor of cytokine signaling 1, inhibiting the activation of JAK-STAT3 pathway and blocking the activation of T lymphocytes.
Keywords: JAK-STAT3; SOCS1; atopic dermatitis; janus kinase; oxymatrine.
Copyright © 2023 Han, Ma, Wang, Jin, Han, Liu and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Naringenin ameliorates atopic dermatitis by inhibiting inflammation and enhancing immunity through the JAK2/STAT3 pathway.Genes Genomics. 2024 Mar;46(3):333-340. doi: 10.1007/s13258-023-01457-8. Epub 2023 Oct 14. Genes Genomics. 2024. PMID: 37837514
-
[Action Mechanism of Ethambutol Tablets on Pulmonary Tuberculosis Rat Model Based on Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022 Aug;44(4):555-562. doi: 10.3881/j.issn.1000-503X.14923. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022. PMID: 36065686 Chinese.
-
Ghrelin inhibits inflammatory response and apoptosis of myocardial injury in septic rats through JAK/STAT signaling pathway.Eur Rev Med Pharmacol Sci. 2020 Nov;24(22):11740-11746. doi: 10.26355/eurrev_202011_23825. Eur Rev Med Pharmacol Sci. 2020. PMID: 33275272
-
Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis.Molecules. 2022 Jul 21;27(14):4660. doi: 10.3390/molecules27144660. Molecules. 2022. PMID: 35889539 Free PMC article. Review.
-
The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review.J Clin Med. 2022 Jul 29;11(15):4431. doi: 10.3390/jcm11154431. J Clin Med. 2022. PMID: 35956047 Free PMC article. Review.
Cited by
-
Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins.Cells. 2024 Mar 13;13(6):505. doi: 10.3390/cells13060505. Cells. 2024. PMID: 38534350 Free PMC article. Review.
-
Therapeutic effects of the Qingre-Qushi recipe on atopic dermatitis through the regulation of gut microbiota and skin inflammation.Heliyon. 2024 Feb 8;10(4):e26063. doi: 10.1016/j.heliyon.2024.e26063. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38380039 Free PMC article.
-
Anti-Inflammatory Effects of the LK5 Herbal Complex on LPS- and IL-4/IL-13-Stimulated HaCaT Cells and a DNCB-Induced Animal Model of Atopic Dermatitis in BALB/c Mice.Pharmaceutics. 2023 Dec 27;16(1):40. doi: 10.3390/pharmaceutics16010040. Pharmaceutics. 2023. PMID: 38258052 Free PMC article.
-
Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases.Int J Nanomedicine. 2023 Jul 10;18:3745-3760. doi: 10.2147/IJN.S415728. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37457799 Free PMC article.
References
-
- Chang J., Yao Z. F., Zhang D., Wang L. (2020). Study on mechanism of compound glycyrrhizin in treatment of atopic dermatitis in mice based on miR-155/SOCS1 axis. Chin. J. Immunol. 36 (13), 1583–1588. 10.3969/j.issn.1000-484X.2020.13.009 - DOI
-
- Dhanushkodi N., Srivastava R., Prakash S., Roy S., Coulon P. G. A., Vahed H., et al. (2020). High frequency of gamma interferon-producing PLZFloRORγtlo invariant natural killer 1 cells infiltrating herpes simplex virus 1-infected corneas is associated with asymptomatic ocular herpesvirus infection. J. Virol. 94 (9), 001400. 10.1128/JVI.00140-20 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous